BioNote, Inc. (KRX:377740)
South Korea
· Delayed Price · Currency is KRW 4,925.00
-20.00 (-0.40%)
At close: Mar 27, 2025, 3:30 PM KST
BioNote Market Cap
BioNote has a market cap or net worth of 483.49 billion as of March 28, 2025. Its market cap has increased by 3.78% in one year.
Market Cap
483.49B
Enterprise Value
82.01B
Revenue
102.78B
Ranking
n/a
PE Ratio
8.80
Stock Price
4,925.00
Market Cap Chart
Since December 22, 2022, BioNote's market cap has decreased from 1.08T to 483.49B, a decrease of -55.44%. That is a compound annual growth rate of -30.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 483.49B | 0.58% |
| Dec 30, 2024 | 480.68B | 10.95% |
| Dec 28, 2023 | 433.23B | -50.44% |
| Dec 29, 2022 | 874.10B | -19.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.66T |
| Celltrion | 38.03T |
| ALTEOGEN | 18.79T |
| Yuhan | 8,537.79B |
| SK Biopharmaceuticals | 7,893.98B |
| HLB Co., Ltd. | 7,500.72B |
| Sam Chun Dang Pharm. | 3,930.51B |
| PharmaResearch | 3,506.51B |